CAV1 and neoplasm: Nevertheless, further investigations are necessary to corroborate our findings on the role of endothelial Cav1 as critical regulator for the radiation response of epithelial prostate tumors in more clinical relevant settings, such as fractionated low-dose irradiation as well as with more clinically relevant endpoints including local tumor control and tumor recurrence experiments and will be performed in the future.